CME

Bridging the Gap to Patient Care in Northeast Arkansas – A clinical update series  

Friday October 30, 2026 | 11:30 a.m. | NEA Baptist Conference Center (Lunch Provided)

NEA Baptist Fall 2026 Provider Education Agenda
11:30 – 12:30 – Registration, Lunch, Exhibitors
12:30 – 1:00 pm – The Lifestyle Lever: Using Nutrition and Exercise to Improve Rheumatic Disease Outcomes – Dr. Luebker
1:00 – 1:30 pm – Cutaneous Manifestations of Rheumatic Diseases – Carla Nix, PA
1:30 – 2:00 pm – What’s new in Lupus? – Dr. Sharon Dowell
2:00  – 2:30 pm – Treating Heart Failure with a Reduced Ejection Fraction – Dr. Nephertiti Efeovbokhan
2:30 – 2:45 pm – Break
2:45 – 3:15 pm – A Case from The Rheumatology Clinic – Resident Physician
3:15  – 3:45 pm – Eliminating fears of prescribing Hormone Replacement Therapy- Allison Swanson, FNP-BC
3:45 – 4:15 pm – The Latest in Osteoporosis Treatment – David Eubanks, APRN
4:15 – 4:30 pm – Wrap Up/Closing Remarks
3.5 CMEs
Moderators: Dr. Sharon Dowell, Ashley House, APRN,
Hailey Lucius, APRN, Allison Swanson, APRN

NEA Baptist CME Registration

This field is for validation purposes and should be left unchanged.
Name(Required)
Email(Required)
Address(Required)
Baptist Employee?(Required)

Accreditation & Credit Statements:
Baptist Memorial Health Care Corporation (BMHCC) is accredited by the Southern States CME
Collaborative to provide continuing medical education for physicians.
BMHCC designates this live activity for a maximum of 3.50 AMA PRA Category 1 Credit(s).
Physicians should claim only the credit commensurate with the extent of their participation in
the activity.
Disclosure policy statement:
It is the policy of Baptist Memorial Health Care Corporation (BMHCC) to promote balance,
independence, objectivity, and scientific rigor in all educational activities; to require disclosure
of all financial relationships with ineligible companies from individuals in control of educational
content; to identify and mitigate relevant financial relationships; and to disclose relevant
relationships, or lack thereof, to the audience prior to the CE activity. Presenters are required
to disclose discussions of unlabeled/unapproved uses of drugs or devices during their
presentation